share_log

Piper Sandler Maintains Neutral on Inari Medical, Maintains $50 Price Target

Benzinga ·  Aug 26, 2024 23:47  · Ratings

Piper Sandler analyst Adam Maeder maintains Inari Medical (NASDAQ:NARI) with a Neutral and maintains $50 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment